Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ALLK - Allakos: Successful Midstage Trial Leads To Too High A Valuation


ALLK - Allakos: Successful Midstage Trial Leads To Too High A Valuation

Allakos (ALLK) recently went up 77% in a single trading day after declaring strong positive results from a phase 2 trial. The stock tripled in a matter of days. Then, it launched what Seeking Alpha refers to as an “upsized offering” of $350 million. Normally, even buoyant stocks take a hit after these. ALLK did not. It didn’t falter, but just kept going.

Last year, around the time of its IPO, somebody said that $40 is too high a price to pay for ALLK because it didn’t have a product and was far

Read more ...

Stock Information

Company Name: Allakos Inc.
Stock Symbol: ALLK
Market: NASDAQ
Website: allakos.com

Menu

ALLK ALLK Quote ALLK Short ALLK News ALLK Articles ALLK Message Board
Get ALLK Alerts

News, Short Squeeze, Breakout and More Instantly...